Recombinant SARS-CoV-2 Spike anticorps (RBD)
Aperçu rapide pour Recombinant SARS-CoV-2 Spike anticorps (RBD) (ABIN7271727)
Antigène
Voir toutes SARS-CoV-2 Spike AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- RBD
-
Fonction
- Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgA1 (AM122)
-
Specificité
- This product is a specific antibody against SARS-CoV-2 Spike protein RBD domain.
-
Attributs du produit
- Recombinant Antibodies produced in HEK293. Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgA1 (AM122) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgA1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Spike S1 protein.
-
Immunogène
- Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgA1 (AM122) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgA1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Spike S1 protein.
-
Isotype
- IgA
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Powder
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- SARS-CoV-2 Spike
-
Sujet
- It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
Antigène
-